BCRX
Biocryst Pharm (BCRX)
NASDAQ
$8.14+$0.02 (+0.20%)
Price as of Sep 11, 2026 7:53 PM EDT
  • $2.1B
    Market Cap
  • 2.65%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 42
Valuation
BCRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
2

Momentum Score

Score: 39
Valuation
BCRX
vs History
vs S&P 500
3-Month Momentum
27.13%
12-Month Momentum
31.23%
3-Month Risk Adjusted Momentum
131.36%
12-Month Risk Adjusted Momentum
67.76%

True Yield

N/A
Valuation
BCRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-1.14%
Net Debt Paydown Yield
-0.01%

Financial Health Score

Score: 39
Valuation
BCRX
vs History
vs S&P 500
Ohlson's O-Score
3